Clinical trial
A Clinical Trial of Autologous Bone Marrow-Derived Mesenchymal Stem Cell Transplantation for Precision Therapy in Ischemic Stroke
NCT06997939 is registered in ClinicalTrials.gov with Affiliated Hospital of Nantong University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Clinical Trial of Autologous Bone Marrow-Derived Mesenchymal Stem Cell Transplantation for Precision Therapy in Ischemic Stroke
- Lead sponsor
- Affiliated Hospital of Nantong University
- Phase
- Phase 1/2
- Overall status
- Not yet recruiting
- Start date
- June 1, 2025
- Completion date
- May 31, 2027
- Enrollment
- 12 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.